In this BC type, the expression of GAS5 was associated with tumor size, clinical stage, lymph node metastasis, and survival, suggesting that a high level of tissue GAS5 could favor a good clinical outcome for BC patients [35,36,37]. This evidence concerns the gene GAS5 and breast cancer.